| dc.contributor.author | China, L | en_US |
| dc.contributor.author | Maini, A | en_US |
| dc.contributor.author | Colas, R | en_US |
| dc.contributor.author | Ly, L | en_US |
| dc.contributor.author | Dalli, J | en_US |
| dc.contributor.author | Gilroy, D | en_US |
| dc.contributor.author | O'Brien, A | en_US |
| dc.contributor.author | Infection, ATTIREAP | en_US |
| dc.date.accessioned | 2017-06-22T08:03:36Z | |
| dc.date.available | 2016-10-03 | en_US |
| dc.date.issued | 2017 | en_US |
| dc.date.submitted | 2017-06-21T00:24:46.694Z | |
| dc.identifier.issn | 0168-8278 | en_US |
| dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/24505 | |
| dc.description | Meeting Abstract | en_US |
| dc.description.sponsorship | European Assoc Study Liver | |
| dc.format.extent | S390 - S390 | en_US |
| dc.rights | © 2017. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.title | Plasma lipid mediator (LM) profiling identifies hyper- and hypo-activated groups of patients with ACLF and targeted 20% human albumin solution infusion recalibrates abnormalities | en_US |
| dc.type | Conference Proceeding | |
| dc.rights.holder | Copyright © 2017 Elsevier | |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000401056600868&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 1 | en_US |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 66 | en_US |
| qmul.funder | Starting Grant::European Research Council | en_US |
| qmul.funder | Starting Grant::European Research Council | en_US |
